Onlymyhealth on MSN

Cancer Isn’t Just a Smoker’s Disease Anymore, Expert Shares the Hidden Risks You Should Know

Cancer in nonsmokers is on the rise Read ahead to know the hidden lifestyle and environmental risks doctors want you to watch ...

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...